According to a recent LinkedIn post from TandemStride, feedback from clinical leaders at its Future of Survivorship event identified post-discharge behavioral health assessment tools as a key unmet need. The post indicates that more than a third of respondents prioritized development of workflows around the PCL-5 PTSD measure, with additional demand for SDOH screening and standardized anxiety and depression instruments.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The company’s LinkedIn post highlights that GAD-7, PHQ-9, and tools for alcohol use and pediatric populations were also cited as important areas, suggesting broad interest in structured, technology-enabled follow-up for discharged patients. This focus may signal TandemStride’s intent to expand its platform toward integrated behavioral and social-risk screening, potentially deepening its value proposition for providers and payers managing post-discharge outcomes.
As shared in the post, TandemStride characterizes these requests as indicators of systemic gaps rather than incremental feature additions, implying a product roadmap oriented toward closing care continuity and survivorship monitoring deficits. For investors, this emphasis on evidence-based assessment tools and social determinants may position the company to align with value-based care initiatives and support reimbursement-driven demand in trauma recovery and broader behavioral health markets.